Developing Realistic Pathways in Cost-Effectiveness Models for Psoriasis: What to do When A Biologic Fails

Josephine A. Mauskopf; Doreen Watson McBride; Jo Mauskopf; Doreen Watson McBride; U Mallya; SR Feldman

Developing Realistic Pathways in Cost-Effectiveness Models for Psoriasis

What to do When A Biologic Fails

Mauskopf, J., McBride, D., Mallya, U., & Feldman, SR. (2013). Developing Realistic Pathways in Cost-Effectiveness Models for Psoriasis: What to do When A Biologic Fails. Value in Health, 16(7), A588-A588.

Copy citation

Meet the Experts

View All Experts

Navigate to Josephine A. Mauskopf

Josephine A. Mauskopf

Recent Publications

Article

Treatment preferences among patients with mild-to-moderate atopic dermatitis

December 31, 2023

Article

Understanding how infection prevention influences nurses' task sequencing using a mixed-methods, simulation-based approach

December 01, 2023

Article

Consensus-based framework for evaluating data modernization initiatives

October 01, 2023

Article

∆8-THC-COOH cross-reactivity with cannabinoid immunoassay kits and interference in chromatographic testing methods

September 15, 2023

View All Publications